Does colchicine have an antifibrotic effect on development of interstitial fibrosis in renal allografts of recipients with familial mediterranean fever?

Transplantation Proceedings

Volumn 38, Issue 2, 2006, Pages 473-476

  Ozdemir B H ^a,b   Ozdemir F N ^a   Sezer, S ^a   Sar, A ^a   Haberal, M ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b Ankara Training and Research Hospital Pathology Department   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; COLCHICINE;

CONFERENCE PAPER; CONTROLLED STUDY; DIARRHEA; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYOPATHY; NAUSEA; NEUROPATHY; PRIORITY JOURNAL; RECURRENT DISEASE; VOMITING;

AMYLOIDOSIS, FAMILIAL; ANTI-BACTERIAL AGENTS; BIOPSY; COLCHICINE; FAMILIAL MEDITERRANEAN FEVER; FIBROSIS; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; RETROSPECTIVE STUDIES;

EID: 33645047692     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.12.049     Document Type: Conference Paper

References (18)

1. M. Levy, M. Spino, S.E. Read Colchicine a state of the art review Pharmacotherapy 11 1991 196
2. J.P. Famaey Colchicine in therapy. State of the art and new perspectives for an old drug Clin Exp Rheumatol 6 1988 305
3. C. Cerquaglia, M. Daico, G. Nucera Pharmacological and clinical basis of treatment of Familial Mediterranean fever (FMF) with colchicine or analogues an update Curr Drug Targets Inflamm Allergy 4 2005 117
4. U.N. Das Auto-immunity and prostaglandins Int J Tissue React 3 1981 89
5. D. Kershenobich, F. Vargas, G. Garcia-Tsao Colchicine in the treatment of cirrhosis of the liver N Engl J Med 318 1988 1709
6. P. Entzian, M. Schlaak, U. Seitzer Antiinflammatory and antifibrotic properties of colchicine implications for idiopathic pulmonary fibrosis Lung 175 1997 41
7. T.C. Peterson, R.A. Isbrucker, M.L. Hooper In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists Immunopharmacology 28 1994 259
8. S.I. Rennard, P.B. Bitterman, T. Ozaki Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro the basis of a possible therapeutic approach to the fibrotic disorders Am Rev Respir Dis 137 1988 181
9. R.F. Diegelmann, B. Peterkofsky Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs Proc Natl Acad Sci USA 69 1972 892
10. W.W. Douglas, J.H. Ryu, S.J. Swensen Members of the Lung Study Group Colchicine versus prednisone in the treatment idiopathic pulmonary fibrosis. A randomized prospective study Am J Respir Crit Care Med 158 1998 220
11. D. Alarcon-Segovia, F. Ramos-Niembro, G. Ibanez de Kasep Long-term evaluation of colchicine in the treatment of scleroderma J Rheumatol 6 1979 705
12. C. McClurkin Jr, S.H. Phan, C.H. Hsu Moderate protection of renal function and reduction of fibrosis by colchicine in a model of anti-GBM disease in the rabbit J Am Soc Nephrol 1 1990 257
13. T. Matsumoto, Y. Mizunoe, N. Sakamoto Suitability of colchicine and superoxide dismutase for the suppression of renal scarring following an infection with bacteria showing mannose-sensitive pili Nephron 56 1990 130
14. M. Sobh, A. Sabry, F. Moustafa Effect of colchicine on chronic cyclosporine nephrotoxicity in Sprague-Dawley rats Nephron 79 1998 452
15. C. Li, C.W. Yang, H.J. Ahn Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity Nephron 92 2002 422
16. U. Disel, S. Paydas, A. Dogan Effect of colchicine on cyclosporine nephrotoxicity, reduction of TGF-beta over expression, apoptosis, and oxidative damage an experimental animal study Transplant Proc 36 2004 1372
17. B.H. Özdemir, F.N. Özdemir, Y. Güngen Role of macrophages and lymphocytes in the induction of neovascularization in renal allograft rejection Am J Kidney Dis 39 2002 347
18. T. Suganami, K. Mori, I. Tanaka Role of prostaglandin E receptor EPI subtype in the development of renal injury in genetically hypertensive rats Hypertension 42 2003 1183